Can Recurrence of Cancer in the Oropharynx Be Detected by Blood Samples?
This study investigates if longitudinal analyses of cell-free HPV-DNA in blood samples can be utilized to detect recurrence in patients diagnosed and treated for HPV-positive oropharyngeal squamous cell carcinoma.
Oropharyngeal Squamous Cell Carcinoma (SCC)|Oropharynx Cancer|Oropharynx Cancer, Metastatic|Oropharynx Cancer, Recurrent|Oropharyngeal Carcinoma
DIAGNOSTIC_TEST: Liquid biopsy
Sensitivity and specificity of HPV ddPCR, Sensitivity and specificity of the ddPCR HPV-test compared to clinically or radiologically verified recurrence., At enrollment and at 2 months, 6 months, 12 months, 18 months, 24 months and 36 months after treatment or at suspicion of recurrence.
Time to recurrence by HPV-DNA, Time to recurrence detected by circulating HPV-DNA, From enrollment to three years after treatment|Time to recurrence by clinical/radiological examination, Time to recurrence detected by clinical or radiological examination, From enrollment to three years after treatment|PET/CT, Number of PET/CT scans without detectable recurrence, From enrollment to three years after treatment|Cancer fast-track referrals, Number of referrals to Cancer Fast-track clinical investigations (conducted by an ENT specialist) without any detectable recurrences., From enrollment to three years after treatment|Fear of Recurrence Questionnaire, Quality of Life (QoL) will be evaluated by the Fear of Recurrence Questionnaire (short form) - filled out by patients during follow-up visits, After treatment at 2 months, 6 months, 12 months, 18 months, 24 months and 36 months
This study investigates if longitudinal analyses of cell-free HPV-DNA in blood samples can be utilized to detect recurrence in patients diagnosed and treated for HPV-positive oropharyngeal squamous cell carcinoma.